FIELD: biotechnology.
SUBSTANCE: invention relates to a tumour-specific peptide. Disclosed peptide is selected by a phage peptide library and has one of the following amino acid sequences: YTYDPWLIFPAN (SEQ ID NO 1) or FIPFDPMSMRWE (SEQ ID NO 2). Peptide has high specificity toward human breast cancer cells, including the ones of triple negative phenotype.
EFFECT: address chemotherapy of human breast cancer.
1 cl, 3 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TUMOR-TARGETED PEPTIDE | 2003 |
|
RU2265027C2 |
| TUMOR-TARGETED PEPTIDE | 2004 |
|
RU2273644C2 |
| RECOMBINANT PLASMID pET-15b_T3_RL DNA PROVIDING SYNTHESIS OF RECOMBINANT FUSION PROTEIN CONSISTING OF TUMOR-SPECIFIC PEPTIDES AND ANTITUMOR PEPTIDE RL2, AND RECOMBINANT FUSION PROTEIN POSSESSING ANTI-TUMOR ACTIVITY AGAINST HUMAN BREAST CANCER | 2016 |
|
RU2619053C1 |
| RECOMBINANT PLASMID pET-15b_T1_RL DNA PROVIDING SYNTHESIS OF RECOMBINANT FUSION PROTEIN CONSISTING OF TUMOR-SPECIFIC PEPTIDES AND ANTITUMOR PEPTIDE RL2, AND RECOMBINANT FUSION PROTEIN POSSESSING CYTOTOXIC ACTIVITY AGAINST CANCER CELLS AND TARGETED PROPERTIES AGAINST TUMOR TISSUE | 2016 |
|
RU2619050C1 |
| PEPTIDE-SIMULATOR OF PROTEIN GP120 HIV-1 EPITOPE | 2000 |
|
RU2184780C2 |
| NEW ANTIBODY SHOWING SPECIFICITY TO MALIGNANT LARGE INTESTINE TUMOR | 2001 |
|
RU2268068C2 |
| PEPTIDE-SIMULATOR OF HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS PROTEIN GP41 CONSERVATIVE EPITOPE RECOGNIZED BY VIRUS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 (VARIANTS) | 2000 |
|
RU2179980C2 |
| METHOD OF SCREENING PHAGE DISPLAY LIBRARY | 2005 |
|
RU2402777C2 |
| RECOMBINANT FRAGMID DNA pHEN-TAB CONTAINING HUMAN SINGLE-STRAND ANTIBODY GENE, CAPABLE OF BINDING OF HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT Escherichia coli BACTERIA STRAIN AS PRODUCER OF HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT SOLUBLE HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA | 2005 |
|
RU2307163C2 |
| PEPTIDES CAPABLE OF REACTIVATING P53 MUTANTS | 2014 |
|
RU2693487C2 |
